Expertise in
2
conditions

Dr. Imtiaz Alam

Hepatology
Zhengzhou, CN 
Accepting New Patients
Offers Telehealth
Expertise in
2
conditions
Zhengzhou, CN 

Overview

Imtiaz Alam is a Hepatologist practicing medicine in Zhengzhou, China.

Dr. Alam is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, Non-Alcoholic Fatty Liver Disease, Colonoscopy, and Endoscopy.

He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 3 clinical trials. Dr. Alam is currently accepting new patients.

Specialties

Hepatology

Languages Spoken

English
Spanish

Gender

Male

Locations

Zhengzhou, China
Other Locations
Tallahassee, FL
Austin, TX

Additional Areas of Focus

Dr. Alam has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Enrollment Status: Completed
Publish Date: February 28, 2024
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

6 Total Publications

Psychometric properties of Tigrigna version medical outcomes study short Form-36 (MOS SF-36) quality of life tool among pulmonary tuberculosis patients in Tigray region, Northern Ethiopia. A Cross-sectional study design.
Psychometric properties of Tigrigna version medical outcomes study short Form-36 (MOS SF-36) quality of life tool among pulmonary tuberculosis patients in Tigray region, Northern Ethiopia. A Cross-sectional study design.
Journal: Chronic illness
Published: August 26, 2026

Frequently Asked Questions about Dr. Imtiaz Alam

Is Dr. Imtiaz Alam a top-rated expert for Hepatitis C?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Imtiaz Alam is classified as an Distinguished expert for Hepatitis C, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Imtiaz Alam specialize in?

While Dr. Imtiaz Alam is a Hepatology, they have specific expertise in Hepatitis C, Hepatitis, and Colonoscopy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hepatology.

Does Dr. Imtiaz Alam participate in research or clinical trials?

Yes. Dr. Imtiaz Alam has published 6 articles and abstracts on conditions like Hepatitis C. You can view a list of Dr. Imtiaz Alam's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Imtiaz Alam accept my insurance?

Dr. Imtiaz Alam accepts most major insurance plans, including Alliant Health and Blue Cross Blue Shield. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Alam's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile